TMEM43 Inhibitors encompass a diverse group of compounds that can influence the activity or expression of the TMEM43 protein. These compounds are characterized not by their direct interaction with TMEM43 but by their ability to modulate pathways and processes that are associated with the protein. The indirect nature of these inhibitors arises from the complex interplay of signaling networks within the cell, where the modulation of one pathway can impact the behavior of interconnected proteins. Among the TMEM43 inhibitors, we have mTOR and PI3K inhibitors like Rapamycin and LY294002 respectively. Rapamycin works by inhibiting mTOR, which in turn can influence a plethora of proteins associated with cell growth and metabolism. LY294002, on the other hand, targets PI3K, subsequently affecting the Akt signaling pathway and thus proteins downstream, which can include TMEM43. U0126 and PD98059 are MEK inhibitors, which modulate the ERK signaling pathway.
Such adjustments in cellular signaling can have a cascade effect, where the inhibition of one protein leads to alterations in the behavior of several others. Similarly, SP600125, a JNK inhibitor, affects the stress-activated pathways, which can influence TMEM43's activity. SB203580, a known inhibitor of p38 MAPK, plays a role in modulating the inflammatory and stress response pathways. The modulation of these pathways provides an avenue through which TMEM43's role or expression in the cell can be influenced. Further, compounds like AG490 target the JAK2 enzyme, influencing cytokine signaling which may affect TMEM43's expression. Then, we have compounds like BAY 11-7082 and PDTC, which are NF-κB inhibitors, a pathway that regulates many genes' expression. Finally, a compound like Metformin, known for its effects on cellular metabolism, can influence multiple signaling pathways and subsequently impact TMEM43. In essence, TMEM43 inhibitors, as currently understood, target a myriad of pathways that, in their modulation, can indirectly influence the function or expression of TMEM43.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
A known mTOR inhibitor. By inhibiting mTOR, it can influence various proteins related to cell growth and metabolism, possibly affecting TMEM43 indirectly. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can affect stress-activated pathways, which might influence the activity or expression of TMEM43 indirectly. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that can modulate inflammatory and stress response pathways, potentially affecting TMEM43's role or expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor with a different mechanism than LY294002, can still impact the Akt pathway and potentially affect TMEM43. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
JAK2 inhibitor that can modulate cytokine signaling, possibly affecting TMEM43 expression or function indirectly. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB pathway inhibitor. As NF-κB regulates many genes' expression, it can potentially affect TMEM43 indirectly. | ||||||
Pyrrolidinedithiocarbamic acid ammonium salt | 5108-96-3 | sc-203224 sc-203224A | 5 g 25 g | $33.00 $64.00 | 11 | |
Another NF-κB inhibitor, might influence TMEM43 by modulating the expression of various genes related to this pathway. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Known for its effects on cellular metabolism, can influence multiple signaling pathways, potentially having an indirect effect on TMEM43. | ||||||